56 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
13 May 19
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
attributable to an increase in non-cash stock compensation offset by reductions in market research costs and professional fees.
Net Loss: Net loss
DEFA14A
ujvb7s xma0
30 Apr 18
Additional proxy soliciting materials
7:03am
8-K
EX-99.1
4op9p615157i
14 Aug 19
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
12:00am
8-K
EX-99.1
85twkg7n
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
8-K
EX-99.1
6zvo j5318fbc
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
ppo10k atai3q44q
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
DEFA14A
scqaz2
29 May 20
Additional proxy soliciting materials
9:30am
DEFA14A
6qc94m6s3x g2kja
25 Jan 19
Additional proxy soliciting materials
1:56pm
8-K
EX-10.4
2yga98b8bpa6u3
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm